SEC Comment Letter 0000000000-24-007120 to Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc.
Date: June 24, 2024 · CIK: 0001704287 · Accession: 0000000000-24-007120
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280253
Letter
United States securities and exchange commission logo June 24, 2024 Neil Dey Chief Executive Officer Bluejay Diagnostics, Inc. 360 Massachusetts Avenue, Suite 203 Acton, MA 01720 Re:Bluejay Diagnostics, Inc. Registration Statement on Form S-1 Filed June 17, 2024 File No. 333-280253 Dear Neil Dey: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Brian C. O'Fahey
Show Raw Text
United States securities and exchange commission logo
June 24, 2024
Neil Dey
Chief Executive Officer
Bluejay Diagnostics, Inc.
360 Massachusetts Avenue, Suite 203
Acton, MA 01720
Re:Bluejay Diagnostics, Inc.
Registration Statement on Form S-1
Filed June 17, 2024
File No. 333-280253
Dear Neil Dey:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Brian C. O'Fahey